minoxidil has been researched along with finasteride in 161 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (11.18) | 18.2507 |
2000's | 46 (28.57) | 29.6817 |
2010's | 48 (29.81) | 24.3611 |
2020's | 49 (30.43) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brunden, MN; Buhl, AE; Diani, AR; Johnson, GA; Kubicek, MF; Mulholland, MJ; Schostarez, HJ; Shull, KL | 1 |
Dunn, CL; James, WD; Walsh, DS | 1 |
Rand, S | 1 |
Piérard, GE; Piérard-Franchimont, C | 1 |
Davies, K | 1 |
Price, VH; Shapiro, J | 1 |
Aubin, F; Esteve, E | 1 |
Bergfeld, WF | 1 |
Sinclair, R | 1 |
Sinclair, RD; Tran, D | 1 |
Nolte, RS; Scow, DT; Shaughnessy, AF | 1 |
Piraccini, BM; Tosti, A | 1 |
Price, VH | 2 |
Sawaya, M | 1 |
Cash, TF | 1 |
Barth, JH | 1 |
Kunte, C; Wolff, H | 1 |
Wasielewski, S | 1 |
Chamberlain, M; Hogan, DJ | 1 |
Saiag, P | 1 |
Granel, F | 1 |
Messenger, AG | 1 |
Meidan, VM; Touitou, E | 1 |
Patel, JC | 1 |
de Viragh, PA; Trüeb, RM | 1 |
Sinclair, RD | 1 |
Sawaya, ME | 1 |
Olsen, EA | 1 |
Hannuksela, M | 1 |
Bader, U; Trüeb, RM | 1 |
Khandpur, S; Reddy, BS; Suman, M | 1 |
Avram, MR; Cole, JP; Gandelman, M; Haber, R; Knudsen, R; Leavitt, MT; Leonard, RT; Puig, CJ; Rose, PT; Vogel, JE; Ziering, CL | 1 |
Hoffmann, R | 1 |
Hanneken, S; Kruse, R; Nöthen, MM; Ritzmann, S | 1 |
Kumar, B; Saraswat, A | 1 |
Iorizzo, M; Tosti, A; Vincenzi, C | 1 |
Trüeb, RM | 1 |
Ellis, JA; Harrap, SB; Sinclair, R | 1 |
Bouhanna, P | 1 |
Bandaranayake, I; Mirmirani, P | 1 |
Haber, RS | 1 |
Açikgöz, G; Arca, E; Köse, O; Kurumlu, Z; Taştan, HB | 1 |
Itami, S | 2 |
Bergfeld, WF; Hordinsky, MK; Messenger, AG; Olsen, EA; Roberts, JL; Shapiro, J; Stough, D; Washenik, K; Whiting, DA | 1 |
Bienová, M; Fiurásková, M; Hajdúch, M; Koláŕ, Z; Kucerová, R | 1 |
Simon, HB | 1 |
Haber, R; Parsley, WM; Stenn, K; Stough, D; Vogel, JE; Washenik, K; Whiting, DA | 1 |
Camacho Martínez, F; Moreno-Ramírez, D | 1 |
Epstein, JS | 1 |
Tsiskarishvili, NV; Tsiskarishvili, TsI | 1 |
Finner, AM; Otberg, N; Shapiro, J | 1 |
Avram, MR; Rogers, NE | 2 |
Scheinfeld, N | 1 |
Alsantali, A; Shapiro, J | 1 |
Duque-Estrada, B; Piraccini, BM; Sisti, A; Tosti, A | 1 |
Karamanovski, E; Lam, SM | 1 |
Cantatore-Francis, J; Gonzalez, ME; Orlow, SJ | 1 |
Rathnayake, D; Sinclair, R | 1 |
Ghanaat, M | 1 |
Jandali, S; Low, DW | 1 |
McDonough, PH; Schwartz, RA | 1 |
Dawson, TL; Patel, M; Perez, A; Rufaut, NW; Sinclair, R; Yazdabadi, A; Yip, L | 1 |
Inui, S; Itami, S; Katsuoka, K; Kono, T; Kurata, S; Manabe, M; Saito, N; Tsuboi, R; Ueki, R; Yamazaki, M | 1 |
Bergstrom, KG | 1 |
McElwee, KJ; Shapiro, JS | 1 |
Banka, N; Bunagan, MJ; Shapiro, J | 1 |
Tanglertsampan, C | 1 |
Basra, MK; Bhatti, HA; Patel, GK | 1 |
Nusbaum, AG; Nusbaum, BP; Rose, PT | 1 |
Ferreira, D; Gomes, MJ; Martins, S; Reis, S; Segundo, MA | 1 |
Bergfeld, WF; Varothai, S | 1 |
Bechtel, MA; Harfmann, KL | 1 |
Danesh, M; Murase, JE | 1 |
Goodier, M; Hordinsky, M | 1 |
Torres, F | 1 |
Ioannides, D; Lazaridou, E | 1 |
Wolff, H | 1 |
Vary, JC | 1 |
Hugh Rushton, D; Norris, MJ; Van Neste, D | 1 |
Fedorowicz, Z; Schoones, J; van Zuuren, EJ | 1 |
Hwang, ST; Jung, JH; Kim, JC; Lee, IJ; Lee, YR | 1 |
Anzalone, A; Carlesimo, M; Caro, G; Fortuna, MC; Garelli, V; Pranteda, G; Rossi, A | 1 |
Blume-Peytavi, U; Fischer, TW; Wolff, H | 1 |
Blanco, A; Kelly, Y; Tosti, A | 1 |
Li, Q; Wu, M; Yu, Q | 1 |
Reygagne, P | 1 |
Fedorowicz, Z; van Zuuren, EJ | 1 |
Adil, A; Godwin, M | 1 |
Alves, R; Grimalt, R | 1 |
Baek, SY; Kang, G; Kang, H; Kim, J; Kim, NS; Lee, JH; Park, HN; Park, S; Park, SK | 1 |
Blume-Peytavi, U; Blumeyer, A; Del Marmol, V; Dobos, G; Finner, A; Kanti, V; Messenger, A; Nast, A; Piraccini, BM; Reygagne, P; Tosti, A; Trakatelli, M | 1 |
Baek, SY; Kang, H; Lee, JH; Lee, YM; Park, HN; Park, SK | 1 |
Dotzert, MS; Gupta, AK; Mays, RR; Piguet, V; Shear, NH; Versteeg, SG | 1 |
Amoh, Y; Inui, S; Itami, S; Ito, T; Kono, T; Kurata, S; Manabe, M; Nakamura, M; Narusawa, H; Ohyama, M; Osada, SI; Saito, N; Sato, A; Shimomura, Y; Tsuboi, R; Ueki, R; Yamazaki, M | 1 |
Anitua, E; Jaén, P; Navarro, MR; Pino, A | 1 |
Chalermroj, N; Khunkhet, S; Srisuwanwattana, P; Suchonwanit, P | 1 |
Iamsumang, W; Rojhirunsakool, S; Suchonwanit, P | 1 |
Andy, G; Aseem, S; John, M; Maja, K; Michael, K; Mirna, S; Rachita, D; Zeljana, B | 1 |
Araujo, LR; de Mattos Barreto, T; Melo, DF; Plata, GT; Tortelly, VD | 1 |
Asnaashari, S; Javadzadeh, Y | 1 |
Beck, R; da Silva, C; Katzer, T; Leite Junior, A | 1 |
Burroway, B; Griggs, J; Tosti, A | 1 |
Fernandez-Nieto, D; Jimenez-Cauhe, J; Moreno-Arrones, OM; Ortega-Quijano, D; Saceda-Corralo, D; Vaño-Galvan, S | 1 |
Pirmez, R; Salas-Callo, CI | 1 |
Van Neste, D | 1 |
Bhoyrul, B; Meah, N; Sinclair, R; York, K | 1 |
Marks, DH; Senna, MM | 1 |
Chen, B; Chen, L; Wang, H; Wang, L; Zhang, J | 1 |
Bamimore, MA; Foley, KA; Gupta, AK | 1 |
Garcovich, S; Gentile, P | 1 |
Kochhar, A; Tai, T | 1 |
Chen, G; Gu, Z; Yang, G | 1 |
Chen, C; Fan, Z; Hu, Z; Miao, Y; Qu, Q; Wang, J; Zhang, C; Zhou, Y | 1 |
Cinelli, E; Fabbrocini, G; Ocampo-Candiani, J; Ocampo-Garza, SS; Villani, A | 1 |
Makki, M; Salah, I; Younes, AH | 1 |
Amin, PD; Jha, DK; Shah, DS | 1 |
Jianmongkol, S; Ngampanya, A; Ongpipattanakul, B; Patel, N; Pornputtapong, N; Prueksaritanont, T; Sermsappasuk, P; Udomnilobol, U | 1 |
Doshi, K; Kapoor, R; Kumar, V; Patel, G; Shome, D; Vadera, S | 1 |
Rose, PT | 1 |
Ablon, G; Fischer, DL; Gade, A; Han, H; Nestor, MS | 1 |
Dommasch, ED; Gao, JL; Peebles, JK; Streed, CG; Thompson, J | 1 |
Carla Jorge, M; de Barros, CC; de Melo Carvalho, R; Melo, DF; Saceda-Corralo, D; Starace, M; Tosti, A; Weffort, F | 1 |
Liu, C; Wu, W; Zhang, Y; Zhao, H | 1 |
Bamimore, MA; Gupta, AK; Talukder, M | 1 |
Bamimore, MA; Gupta, AK; Talukder, M; Venkataraman, M | 1 |
Faghihi, G; Hoseyni, MS; Iraji, F; Jelvan, M; Saber, M; Siadat, AH | 1 |
Gupta, AK; Talukder, M | 1 |
Gómez-Flores, M; Herz-Ruelas, ME; Martínez-Moreno, A; Ocampo-Candiani, J; Ocampo-Garza, J; Ocampo-Garza, SS; Orizaga-Y-Quiroga, TL; Sánchez-Meza, E | 1 |
Gao, S; Jia, Z; Li, K; Tian, K; Wu, L; Xu, W | 1 |
Gupta, AK; Talukder, M; Williams, G | 1 |
Sand, J; Walen, S | 2 |
de Dios Berna-Rico, E; Fernandez-Nieto, D; Hermosa-Gelbard, A; Jimenez-Cauhe, J; Moreno-Arrones, OM; Ortega-Quijano, D; Pindado-Ortega, C; Saceda-Corralo, D; Vaño-Galvan, S | 1 |
Domínguez-Santas, M; Grimalt, R; Saceda-Corralo, D; Vañó-Galván, S | 1 |
Mahajan, C; Shapiro, J; Tosti, A; Young, PC | 1 |
Arruda, S; Haddad, N; Sadick, N | 1 |
Chen, G; Fu, Q; Jia, L; Li, N; Zhou, D; Zhou, Y | 1 |
Gomes, TF; Soares, RO | 1 |
Behrangi, E; Ghassemi, M; Goodarzi, A; Nikkhah, F; Nobari, NN; Roohaninasab, M; Sadeghzadeh-Bazargan, A | 1 |
Beley, N; Bjørklund, G; Fedorovska, M; Gasmi, A; Komisarenko, A; Lenchyk, L; Lysiuk, R; Muhammad, A; Mujawdiya, PK; Noor, S; Piscopo, S; Shanaida, M; Strus, O | 1 |
Devjani, S; Ezemma, O; Kelley, KJ; Senna, M; Stratton, E | 1 |
Abidi, Z; Arruda, S; Rapaport, J; Sadgrove, NJ; Sadick, N; Swearingen, A | 1 |
Deoghare, S; Sadick, NS | 1 |
Chen, J; Li, Y; Lv, Y; Miao, X; Xiang, H; Xu, S; Xue, X; Zhang, W | 1 |
Arruda, S; Farah, RS; Fruechte, S; Hordinsky, MK; Ly, NY; Sadick, N | 1 |
Li, Z; Lin, J; Liu, Q; Ni, C; Wang, Q; Wu, W; Yang, K; Zhu, Y | 1 |
Da Matta, SLP; Da Silva, J; Gonçalves, RV; Lozi, AA; Santana, FFV | 1 |
Hu, L; Luo, F; Zhang, X; Zhao, H | 1 |
88 review(s) available for minoxidil and finasteride
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Male alopecia: etiopathogenic concepts and current therapies].
Topics: 5-alpha Reductase Inhibitors; Alopecia; Female; Finasteride; Humans; Inflammation; Male; Minoxidil; Severity of Illness Index; Vasodilator Agents | 1997 |
Hair regrowth. Therapeutic agents.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia; Alopecia Areata; Androgen Antagonists; Animals; Anthralin; Anti-Inflammatory Agents; Child; Cyproterone Acetate; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; PUVA Therapy; Spironolactone | 1998 |
[Androgenetic alopecia].
Topics: Alopecia; Enzyme Inhibitors; Finasteride; Humans; Male; Minoxidil; Treatment Outcome; Vasodilator Agents | 1997 |
Male pattern androgenetic alopecia.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Alopecia; Androgens; Antihypertensive Agents; Enzyme Inhibitors; Finasteride; Hair; Humans; Male; Minoxidil | 1998 |
Understanding and managing common baldness.
Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Hair; Humans; Incidence; Male; Minoxidil; Sex Distribution; Spironolactone; Treatment Outcome | 1999 |
Medical treatments for balding in men.
Topics: Alopecia; Finasteride; Hair; Humans; Male; Minoxidil; Patient Education as Topic; Severity of Illness Index; Teaching Materials | 1999 |
Androgenetic alopecia.
Topics: Alopecia; Female; Finasteride; Humans; Male; Minoxidil | 1999 |
Treatment of hair loss.
Topics: 5-alpha Reductase Inhibitors; Administration, Topical; Alopecia; Alopecia Areata; Anthralin; Anti-Inflammatory Agents; Contraindications; Enzyme Inhibitors; Female; Finasteride; Glucocorticoids; Hair; Humans; Immunotherapy; Male; Minoxidil | 1999 |
The psychosocial consequences of androgenetic alopecia: a review of the research literature.
Topics: Alopecia; Body Image; Culture; Enzyme Inhibitors; Female; Finasteride; Humans; Interpersonal Relations; Male; Minoxidil; Quality of Life; Self Concept; Vasodilator Agents | 1999 |
Finasteride revisited: Proscar for the prostate and Propecia for the pate.
Topics: Adrenergic alpha-Antagonists; Alopecia; Enzyme Inhibitors; Finasteride; Humans; Male; Minoxidil; Prostatic Hyperplasia | 2000 |
[Drug treatment of androgenetic alopecia in men].
Topics: Adult; Alopecia; Finasteride; Humans; Male; Minoxidil | 2000 |
Male pattern baldness.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Age of Onset; Alopecia; Coronary Disease; Enzyme Inhibitors; Finasteride; Hair; Humans; Male; Mental Disorders; Minoxidil; Vasodilator Agents | 2000 |
Medical management of male pattern hair loss.
Topics: Alopecia; Enzyme Inhibitors; Finasteride; Hair Follicle; Humans; Minoxidil | 2000 |
Treatments for androgenetic alopecia and alopecia areata: current options and future prospects.
Topics: Adrenal Cortex Hormones; Alopecia; Animals; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Genetic Therapy; Hair Follicle; Humans; Male; Minoxidil; Phytotherapy; Vasodilator Agents | 2001 |
Hair loss.
Topics: Adult; Alopecia; Child; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Finasteride; Humans; Male; Minoxidil; Vasodilator Agents | 2000 |
Management of male pattern hair loss.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Alopecia; Enzyme Inhibitors; Finasteride; Hair; Humans; Male; Middle Aged; Minoxidil; Vasodilator Agents | 2001 |
Baldness. Medical solutions for men and women.
Topics: Alopecia; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; Scalp; Sex Factors; Vasodilator Agents | 2001 |
Androgenetic alopecia: overview.
Topics: Alopecia; Androgens; Enzyme Inhibitors; Female; Finasteride; Humans; Male; Minoxidil; Nonprescription Drugs; Sex Characteristics; Skin; Vasodilator Agents | 1999 |
[Loss of hair].
Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Hair; Hormone Antagonists; Humans; Male; Minoxidil; Sex Factors; Spironolactone; Surgery, Plastic; Treatment Outcome | 2000 |
The potential role of minoxidil in the hair transplantation setting.
Topics: Administration, Oral; Administration, Topical; Alopecia; Combined Modality Therapy; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; Patient Compliance; Vasodilator Agents | 2002 |
[Androgenetic alopecia. Current aspects of a common phenotype].
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Alopecia; Disease Progression; Enzyme Inhibitors; Female; Finasteride; Genetic Predisposition to Disease; Hair; Hair Follicle; Humans; Male; Middle Aged; Minoxidil; Vasodilator Agents | 2003 |
Androgenetic alopecia: pathogenesis and potential for therapy.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Alopecia; Dihydrotestosterone; Female; Finasteride; Genes, Dominant; Hair Follicle; Humans; Male; Middle Aged; Minoxidil; Receptors, Androgen | 2002 |
Hair loss remedies--separating fact from fiction.
Topics: Alopecia; Azasteroids; Dietary Supplements; Dutasteride; Enzyme Inhibitors; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Mineralocorticoid Receptor Antagonists; Minoxidil; Spironolactone; Treatment Outcome; Vasodilator Agents | 2004 |
Pharmacologic management of pattern hair loss.
Topics: Administration, Topical; Alopecia; Androgen Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Finasteride; Humans; Ketoconazole; Male; Minoxidil; Treatment Outcome | 2004 |
[Pathomechanism of androgenetic alopecia and new treatment].
Topics: Alopecia; Androgens; Animals; Coculture Techniques; Finasteride; Hair Follicle; Humans; Insulin-Like Growth Factor Binding Protein 1; Keratinocytes; Male; Mice; Minoxidil; Receptors, Androgen; Skin | 2004 |
Androgenetic alopecia and current methods of treatment.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Enzyme Inhibitors; Female; Finasteride; Hair; Hair Follicle; Humans; Male; Minoxidil; Vasodilator Agents | 2005 |
Psychological effect, pathophysiology, and management of androgenetic alopecia in men.
Topics: Alopecia; Finasteride; Hair; Humans; Male; Minoxidil | 2005 |
Androgenetic alopecia.
Topics: Alopecia; Androgens; Comorbidity; Finasteride; Humans; Male; Minoxidil; Models, Biological; Prevalence; Risk Factors; Surgery, Plastic | 2007 |
[Hair follicle regeneration].
Topics: Alopecia; Animals; Cell- and Tissue-Based Therapy; Dermis; Finasteride; Hair; Hair Follicle; Humans; Minoxidil; Receptors, Androgen; Regeneration; Scalp; Stem Cells | 2008 |
Hair transplantation for men.
Topics: Alopecia; Cicatrix; Cosmetic Techniques; Finasteride; Hair; Hair Follicle; Humans; Low-Level Light Therapy; Male; Minoxidil; Scalp | 2008 |
A review of hormonal therapy for female pattern (androgenic) alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Dermatologic Agents; Enzyme Inhibitors; Female; Finasteride; Flutamide; Humans; Minoxidil; Spironolactone; Testosterone | 2008 |
Medical treatments for male and female pattern hair loss.
Topics: Adult; Alopecia; Androgen Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Female; Finasteride; Hair; Humans; Hyperhidrosis; Ketoconazole; Male; Minoxidil; Phototherapy; Prostate; Sperm Count; Tretinoin | 2008 |
Androgens and hair loss.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgens; Animals; Azasteroids; Dutasteride; Enzyme Inhibitors; Finasteride; Genetic Predisposition to Disease; Hair; Humans; Male; Minoxidil; Risk Factors; Testosterone; Treatment Outcome | 2009 |
Hair loss in women.
Topics: Alopecia; Biotin; Contraceptives, Oral, Hormonal; Female; Finasteride; Gonadal Steroid Hormones; Hair Follicle; Humans; Iron; Iron Deficiencies; Minoxidil; Pregnancy; Pregnancy Complications; Puerperal Disorders; Stress, Psychological; Substance Withdrawal Syndrome; Trichotillomania | 2009 |
Hair restoration in the ethnic patient and review of hair transplant fundamentals.
Topics: Alopecia; Enzyme Inhibitors; Esthetics; Ethnicity; Finasteride; Hair; Hair Follicle; Humans; Minoxidil | 2010 |
Male androgenetic alopecia.
Topics: Administration, Oral; Administration, Topical; Alopecia; Androgen Receptor Antagonists; Azasteroids; Combined Modality Therapy; Dutasteride; Finasteride; Genetic Predisposition to Disease; Hair; Humans; Male; Men's Health; Minoxidil; Polymorphism, Genetic; Receptors, Androgen | 2010 |
Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism.
Topics: Alopecia; Androgens; Dermatologic Agents; Drugs, Investigational; Female; Finasteride; Humans; Male; Minoxidil; Off-Label Use; Phototherapy; Tretinoin | 2010 |
From surgery to pharmacology to gene therapy: the past, present, and future of hair restoration.
Topics: Alopecia; Female; Finasteride; Forecasting; Genetic Therapy; Hair; Hair Follicle; Humans; Male; Minoxidil; Pharmaceutical Preparations; Scalp; Treatment Outcome | 2010 |
Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Cosmetic Techniques; Female; Finasteride; Hair; Hair Preparations; Humans; Minoxidil; Scalp Dermatoses | 2011 |
Promising therapies for treating and/or preventing androgenic alopecia.
Topics: Alopecia; Female; Finasteride; Hair; Humans; Laser Therapy; Male; Minoxidil; Sex Factors | 2012 |
Pattern hair loss in men: diagnosis and medical treatment.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgens; Azasteroids; Dutasteride; Female; Finasteride; Genetic Predisposition to Disease; Hair Follicle; Humans; Male; Minoxidil; Vasodilator Agents | 2013 |
Hair restoration approaches for early onset male androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Azasteroids; Cosmetic Techniques; Drug Therapy, Combination; Dutasteride; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Tissue and Organ Harvesting; Vasodilator Agents | 2013 |
Nonsurgical therapy for hair loss.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Azasteroids; Combined Modality Therapy; Dutasteride; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Minoxidil; Sex Factors | 2013 |
Androgenetic alopecia: an evidence-based treatment update.
Topics: Administration, Oral; Administration, Topical; Alopecia; Evidence-Based Medicine; Female; Finasteride; Hair; Humans; Male; Minoxidil; Prevalence; Quality of Life; Sex Factors | 2014 |
Hair loss in women.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Female; Finasteride; Flutamide; Hair; Humans; Hypotrichosis; Minoxidil; Phototherapy; Spironolactone; Vasodilator Agents | 2015 |
Normal and aging hair biology and structure 'aging and hair'.
Topics: 5-alpha Reductase Inhibitors; Aging; Alopecia; Finasteride; Hair; Hair Follicle; Humans; Melanocytes; Minoxidil; Phototherapy; Scalp; Stem Cells; Telomere Shortening; Vasodilator Agents | 2015 |
Androgenetic, diffuse and senescent alopecia in men: practical evaluation and management.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Dutasteride; Finasteride; Hair; Humans; Male; Minoxidil; Vasodilator Agents | 2015 |
Female pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents | 2015 |
Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis.
Topics: Acetylcholine Release Inhibitors; Acne Vulgaris; Algorithms; Alopecia; Anti-Bacterial Agents; Antiperspirants; Benzoyl Peroxide; Botulinum Toxins; Contraceptives, Oral, Hormonal; Dermatologic Agents; Finasteride; Hair Follicle; Humans; Hyperhidrosis; Iontophoresis; Mandelic Acids; Minoxidil; Muscarinic Antagonists; Nails; Retinoids; Spironolactone; Sweat Glands; Sympathectomy | 2015 |
Interventions for female pattern hair loss.
Topics: Alopecia; Drug Administration Schedule; Female; Finasteride; Hair; Humans; Low-Level Light Therapy; Minoxidil; Randomized Controlled Trials as Topic | 2016 |
Guidelines on Hair Restoration for East Asian Patients.
Topics: Asia, Eastern; Asian People; Cosmetic Techniques; Dermatologic Agents; Eyebrows; Female; Finasteride; Hair; Humans; Male; Minoxidil; Practice Guidelines as Topic; Tissue and Organ Harvesting; Transplantation | 2016 |
Multi-therapies in androgenetic alopecia: review and clinical experiences.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Administration, Oral; Alopecia; Finasteride; Hair; Humans; Minoxidil; Scalp; Treatment Outcome | 2016 |
The Diagnosis and Treatment of Hair and Scalp Diseases.
Topics: Alopecia; Combined Modality Therapy; Dermatologic Agents; Diagnosis, Differential; Evidence-Based Medicine; Finasteride; Hair; Hormone Replacement Therapy; Humans; Minoxidil; Scalp Dermatoses; Treatment Outcome | 2016 |
Androgenetic Alopecia: An Update of Treatment Options.
Topics: Alopecia; Androgen Antagonists; Animals; Female; Finasteride; Humans; Male; Minoxidil | 2016 |
[Androgenetic alopecia: What's new in the last two years ?]
Topics: Alopecia; Early Diagnosis; Finasteride; France; Gene Expression Regulation; Genetic Association Studies; Genotype; Guideline Adherence; Histone Deacetylases; Humans; Male; Minoxidil; Receptors, Androgen; Repressor Proteins | 2016 |
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Topics: Alopecia; Finasteride; Humans; Low-Level Light Therapy; Minoxidil; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Finasteride; Humans; Low-Level Light Therapy; Minoxidil; Network Meta-Analysis; Platelet-Rich Plasma; Vasodilator Agents | 2018 |
Herbal Medicines For Treatment of Androgenic Alopecia.
Topics: Alopecia; Finasteride; Herbal Medicine; Humans; Minoxidil; Phytotherapy; Plants, Medicinal; Scalp | 2020 |
Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti-androgens.
Topics: Adult; Alopecia; Androgen Antagonists; Finasteride; Genetic Predisposition to Disease; Hair; Humans; Low-Level Light Therapy; Male; Middle Aged; Minoxidil; Platelet-Rich Plasma; Prognosis; Risk Assessment; Treatment Outcome | 2019 |
Pediatric androgenetic alopecia: A review.
Topics: Adolescent; Alopecia; Child; Finasteride; Humans; Incidence; Minoxidil; Retrospective Studies | 2021 |
A review of the treatment of male pattern hair loss
Topics: Administration, Oral; Administration, Topical; Alopecia; Dry Needling; Finasteride; Hair; Humans; Low-Level Light Therapy; Male; Minoxidil; Prostaglandins; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
Androgenetic Alopecia in Gender Minority Patients.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgens; Dermatologic Agents; Estrogens; Finasteride; Hair Follicle; Humans; Low-Level Light Therapy; Minoxidil; Sex Reassignment Procedures; Sexual and Gender Minorities; Tissue Transplantation; Transgender Persons; Transplantation, Autologous | 2020 |
The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Topics: Alopecia; Finasteride; Hair; Humans; Minoxidil; Photography; Treatment Outcome | 2020 |
Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality.
Topics: Alopecia; Female; Finasteride; Humans; Male; Minoxidil; Network Meta-Analysis; Treatment Outcome | 2022 |
Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil
Topics: Adult Stem Cells; Alopecia; Combined Modality Therapy; Finasteride; Humans; Minoxidil; Platelet-Rich Plasma; Stem Cell Transplantation; Treatment Outcome | 2020 |
Physiology and Medical Treatments for Alopecia.
Topics: Alopecia; Dihydrotestosterone; Dutasteride; Finasteride; Hair Preparations; Humans; Low-Level Light Therapy; Minoxidil | 2020 |
Transdermal Drug Delivery for Hair Regrowth.
Topics: Acrylates; Administration, Cutaneous; Alopecia; Drug Carriers; Finasteride; Hair Follicle; Humans; Janus Kinases; Minoxidil; Nanoparticles; Permeability; Signal Transduction; Skin; STAT Transcription Factors; Transdermal Patch; Valproic Acid | 2021 |
The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta-analysis.
Topics: Alopecia; Female; Finasteride; Hair; Humans; Male; Minoxidil; Treatment Outcome | 2020 |
Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature.
Topics: Alopecia; Finasteride; Hair; Humans; Low-Level Light Therapy; Minoxidil | 2020 |
Combination Approaches for Combatting Hair Loss.
Topics: Alopecia; Child; Female; Finasteride; Humans; Male; Middle Aged; Minoxidil | 2021 |
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
Topics: Alopecia; Alopecia Areata; Female; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Quality of Life | 2021 |
Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics.
Topics: Alopecia; Dutasteride; Finasteride; Humans; Minoxidil; Transgender Persons; Treatment Outcome | 2023 |
Natural products for male androgenetic alopecia.
Topics: Alopecia; Biological Products; Finasteride; Humans; Male; Minoxidil; Treatment Outcome | 2022 |
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Bayes Theorem; Dutasteride; Finasteride; Humans; Male; Minoxidil; Network Meta-Analysis; Treatment Outcome; Young Adult | 2022 |
Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?
Topics: Administration, Topical; Alopecia; Clinical Trials, Phase III as Topic; Female; Finasteride; Hair; Humans; Male; Minoxidil; Randomized Controlled Trials as Topic; Tablets; Treatment Outcome | 2022 |
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Finasteride; Hair; Humans; Male; Minoxidil | 2022 |
Noninvasive Hair Rejuvenation.
Topics: Alopecia; Female; Finasteride; Hair; Humans; Male; Minoxidil; Rejuvenation; Treatment Outcome | 2022 |
Advances in microneedles research based on promoting hair regrowth.
Topics: Alopecia; Drug Delivery Systems; Finasteride; Hair; Humans; Minoxidil | 2023 |
Pediatric androgenetic alopecia: an updated review.
Topics: Adolescent; Alopecia; Child; Female; Finasteride; Hair; Humans; Minoxidil; Treatment Outcome | 2023 |
A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia.
Topics: Alopecia; Combined Modality Therapy; Female; Finasteride; Humans; Minoxidil; Postmenopause; Treatment Outcome | 2023 |
Natural Compounds Used for Treating Hair Loss.
Topics: Alopecia; Animals; Bees; Finasteride; Hair; Minoxidil; Plants, Medicinal; Quality of Life; United States | 2023 |
Androgenetic Alopecia: Therapy Update.
Topics: Administration, Oral; Administration, Topical; Alopecia; Female; Finasteride; Humans; Male; Minoxidil; Treatment Outcome | 2023 |
Noninvasive Hair Rejuvenation.
Topics: Alopecia; Female; Finasteride; Hair; Humans; Male; Minoxidil; Rejuvenation; Treatment Outcome | 2023 |
Combination therapy in female pattern hair loss.
Topics: Alopecia; Combined Modality Therapy; Female; Finasteride; Humans; Minoxidil; Spironolactone; Treatment Outcome | 2023 |
Dissolving microneedles for alopecia treatment.
Topics: Alopecia; Female; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Quality of Life; Treatment Outcome | 2023 |
Medical and procedural treatment of androgenetic alopecia - Where are we?
Topics: Alopecia; Behavior Therapy; Dietary Supplements; Finasteride; Humans; Minoxidil | 2023 |
Comparative effects of finasteride and minoxidil on the male reproductive organs: A systematic review of in vitro and in vivo evidence.
Topics: Administration, Oral; Adult; Alopecia; Animals; Finasteride; Humans; Male; Mice; Minoxidil; Prostatic Hyperplasia; Treatment Outcome | 2023 |
13 trial(s) available for minoxidil and finasteride
Article | Year |
---|---|
Propecia and Rogaine Extra Strength for alopecia.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Alopecia; Clinical Trials as Topic; Drug Costs; Enzyme Inhibitors; Finasteride; Hair Follicle; Humans; Male; Middle Aged; Minoxidil; Multicenter Studies as Topic; Vasodilator Agents | 1998 |
Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Administration, Topical; Adolescent; Adult; Alopecia; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Hair Preparations; Humans; Ketoconazole; Male; Minoxidil | 2002 |
An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Alopecia; Analysis of Variance; Dose-Response Relationship, Drug; Drug Administration Schedule; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Minoxidil; Patient Satisfaction; Probability; Reference Values; Statistics, Nonparametric; Treatment Outcome | 2004 |
[Effectiveness of the treatment plan for androgenetic alopecia].
Topics: Adolescent; Adult; Alopecia; Antifungal Agents; Chronic Disease; Enzyme Inhibitors; Female; Finasteride; Humans; Ketoconazole; Male; Middle Aged; Minoxidil; Vasodilator Agents; Zinc | 2007 |
Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Double-Blind Method; Drug Therapy, Combination; Finasteride; Humans; Male; Middle Aged; Minoxidil; Treatment Outcome; Vasodilator Agents | 2012 |
Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study.
Topics: Administration, Topical; Alopecia; Angiogenesis Inducing Agents; Double-Blind Method; Drug Therapy, Combination; Female; Finasteride; Humans; Male; Minoxidil; Platelet-Rich Plasma; Treatment Outcome | 2018 |
A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Adult; Alopecia; Dihydrotestosterone; Double-Blind Method; Drug Combinations; Finasteride; Hair; Humans; Male; Middle Aged; Minoxidil; Photography; Treatment Outcome; Vasodilator Agents | 2018 |
Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Administration, Topical; Aged; Alopecia; Dihydrotestosterone; Double-Blind Method; Drug Therapy, Combination; Female; Finasteride; Hair; Humans; Middle Aged; Minoxidil; Postmenopause; Prospective Studies; Treatment Outcome; Vasodilator Agents | 2019 |
Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol.
Topics: Administration, Topical; Alopecia; Finasteride; Hair; Humans; Male; Minoxidil; Scalp; Treatment Outcome | 2020 |
Clinical observation of basic fibroblast growth factor (bFGF) combined with minoxidil in the treatment of male androgenetic alopecia.
Topics: Alopecia; Fibroblast Growth Factor 2; Finasteride; Humans; Male; Minoxidil; Treatment Outcome | 2022 |
Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.
Topics: Administration, Topical; Alopecia; Finasteride; Flutamide; Humans; Minoxidil; Treatment Outcome | 2022 |
Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study.
Topics: Administration, Topical; Alopecia; Double-Blind Method; Dutasteride; Finasteride; Humans; Minoxidil; Treatment Outcome | 2022 |
A study of combination unilateral subcutaneous botulinum toxin a treatment for androgenetic alopecia.
Topics: Alopecia; Botulinum Toxins, Type A; Finasteride; Humans; Minoxidil; Treatment Outcome | 2022 |
60 other study(ies) available for minoxidil and finasteride
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Administration, Topical; Androstenes; Animals; Azasteroids; Chromatography, High Pressure Liquid; Dihydrotestosterone; Drug Interactions; Finasteride; Hair; Macaca; Male; Minoxidil; Reference Values; Testosterone | 1992 |
Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Alopecia; Cholestenone 5 alpha-Reductase; Enzyme Inhibitors; Finasteride; Humans; Keratolytic Agents; Male; Minoxidil; Oxidoreductases; Pharmaceutical Vehicles; Tretinoin; Vasodilator Agents | 1995 |
Hair growth therapy(ies) for androgenetic alopecia.
Topics: Alopecia; Finasteride; Hair; Humans; Minoxidil; Tretinoin | 1996 |
Human genetics. Hair apparent.
Topics: Alopecia; Animals; Enzyme Inhibitors; Female; Finasteride; Humans; Male; Mice; Minoxidil; Mutation; Proteins; Transcription Factors | 1998 |
Retinoids and hair growth.
Topics: Alopecia; Animals; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Keratolytic Agents; Male; Minoxidil; Retinoids; Tretinoin; Vasodilator Agents | 1998 |
Authors' conflicts of interest: a disclosure and editors' reply.
Topics: Alopecia; Conflict of Interest; Drug Industry; Financial Support; Finasteride; Humans; Minoxidil; Publishing; Research Support as Topic; Review Literature as Topic | 1999 |
Where's the hair?
Topics: Alopecia; Female; Finasteride; Hair; Humans; Male; Minoxidil | 1999 |
Should men still go bald gracefully?
Topics: Alopecia; Enzyme Inhibitors; Finasteride; Hair Follicle; Humans; Male; Minoxidil | 2000 |
[Treatment for hair loss].
Topics: Alopecia; Alopecia Areata; Female; Finasteride; Humans; Male; Minoxidil | 2000 |
[Toward an effective treatment of androgenetic alopecia?].
Topics: Alopecia; Androgens; Female; Finasteride; Humans; Male; Minoxidil; Treatment Outcome | 2000 |
[Androgenetic alopecia: drug treatment].
Topics: Administration, Oral; Alopecia; Androgens; Animals; Clinical Trials as Topic; Female; Finasteride; Humans; Male; Minoxidil; Treatment Outcome | 2000 |
[Status of scalp hair and therapy of alopecia in men in Switzerland].
Topics: Adolescent; Adult; Aged; Alopecia; Cross-Sectional Studies; Cyclic N-Oxides; Finasteride; Humans; Incidence; Male; Middle Aged; Minoxidil; Patient Acceptance of Health Care; Patient Care Team; Pyrimidines; Switzerland | 2001 |
My hair is thinning on the top of my head. What treatments are available for hair loss in women?
Topics: Alopecia; Diuretics; Enzyme Inhibitors; Female; Finasteride; Humans; Minoxidil; Spironolactone; United States; Vasodilator Agents | 2002 |
[Androgenetic alopecia in the man].
Topics: Adult; Age Factors; Aged; Alopecia; Androgens; Finasteride; Hair; Hair Follicle; Humans; Male; Middle Aged; Minoxidil | 2002 |
[TrichoScan. A new instrument for digital hair analysis].
Topics: Adult; Alopecia; Female; Finasteride; Follow-Up Studies; Hair; Hair Diseases; Humans; Image Processing, Computer-Assisted; Male; Microscopy; Minoxidil; Sensitivity and Specificity; Treatment Outcome | 2002 |
Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.
Topics: Adolescent; Adult; Alopecia; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Minoxidil; Randomized Controlled Trials as Topic; Vasodilator Agents | 2003 |
Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
Topics: Administration, Oral; Administration, Topical; Adult; Alopecia; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Minoxidil; Substance Withdrawal Syndrome; Vasodilator Agents | 2003 |
[Hair loss].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alopecia; Alopecia Areata; Biopsy; Child; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Female; Finasteride; Hair; Humans; Male; Middle Aged; Minoxidil; Multicenter Studies as Topic; Placebos; Scalp; Sex Factors; Time Factors | 2003 |
Androgenetic alopecia: combining medical and surgical treatments.
Topics: Alopecia; Combined Modality Therapy; Enzyme Inhibitors; Female; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Skin Transplantation; Vasodilator Agents | 2003 |
Evaluation and treatment of male and female pattern hair loss.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Topical; Adolescent; Adult; Alopecia; Androgen Antagonists; Contraindications; Cosmetic Techniques; Cyproterone Acetate; Diagnosis, Differential; Dihydrotestosterone; Female; Finasteride; Gonadal Steroid Hormones; Hair; Hair Follicle; Humans; Hypothyroidism; Iron Deficiencies; Isoenzymes; Male; Middle Aged; Minoxidil; Receptors, Androgen; Sex Characteristics; Spironolactone | 2005 |
Telling the bald truth.
Topics: Alopecia; Finasteride; Hair; Humans; Male; Minoxidil; United States | 2003 |
Frontal fibrosing alopecia: a survey in 16 patients.
Topics: Aged; Alopecia; Diagnosis, Differential; Disease Progression; Enzyme Inhibitors; Eyebrows; Female; Fibrosis; Finasteride; Glucocorticoids; Humans; Middle Aged; Minoxidil; Postmenopause; Scalp Dermatoses; Treatment Outcome | 2005 |
Finasteride and minoxidil for alopecia revisited.
Topics: Adult; Alopecia; Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Enzyme Inhibitors; Female; Finasteride; Humans; Male; Middle Aged; Minoxidil | 2005 |
Managing hair loss. Treatments may help.
Topics: Alopecia; Dermatologic Agents; Female; Finasteride; Humans; Male; Minoxidil | 2006 |
Evolution of techniques in hair transplantation: a 12-year perspective.
Topics: Adult; Alopecia; Cosmetic Techniques; Disease Progression; Enzyme Inhibitors; Female; Finasteride; Forecasting; Hair; Hair Follicle; Humans; Male; Marketing of Health Services; Middle Aged; Minoxidil; Scalp; Surgical Flaps; Tissue Expansion | 2007 |
Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients.
Topics: Adolescent; Adult; Age of Onset; Alopecia; Biopsy; Diagnosis, Differential; Enzyme Inhibitors; Female; Finasteride; Humans; Male; Minoxidil; New York; Prevalence; Retrospective Studies; Scalp; Sex Distribution; Vasodilator Agents; Young Adult | 2010 |
Adolescent androgenic alopecia.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Alopecia; Diagnosis, Differential; Female; Finasteride; Humans; Male; Minoxidil; Vasodilator Agents | 2011 |
Guidelines for the management of androgenetic alopecia (2010).
Topics: 5-alpha Reductase Inhibitors; Alopecia; Female; Finasteride; Hair; Humans; Male; Minoxidil; Randomized Controlled Trials as Topic; Vasodilator Agents | 2012 |
What's new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women.
Topics: Alopecia; Azasteroids; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Dutasteride; Female; Finasteride; Humans; Male; Minoxidil; Neoplasms; Risk Factors; Time Factors | 2011 |
Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies.
Topics: Administration, Topical; Alopecia; Animals; Delayed-Action Preparations; Dermatologic Agents; Drug Delivery Systems; Drug Stability; Finasteride; Humans; Lipids; Male; Minoxidil; Nanomedicine; Nanoparticles; Nanotechnology; Particle Size; Skin; Surface Properties; Swine | 2014 |
Increasing utility of finasteride for frontal fibrosing alopecia.
Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrosis; Finasteride; Follow-Up Studies; Frontal Bone; Humans; Middle Aged; Minoxidil; Sampling Studies; Severity of Illness Index; Treatment Outcome | 2015 |
[Drug treatment of alopecia].
Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia; Anti-Bacterial Agents; Cyclopropanes; Evidence-Based Medicine; Finasteride; Humans; Minoxidil; Treatment Outcome | 2015 |
Hair regrowth in male and female pattern hair loss does not involve the conversion of vellus hair to terminal hair.
Topics: Adult; Alopecia; Female; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Retrospective Studies | 2016 |
Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.
Topics: 5-alpha Reductase Inhibitors; Adverse Drug Reaction Reporting Systems; Alopecia; Drug-Related Side Effects and Adverse Reactions; Female; Fetus; Finasteride; Gene Expression Regulation; Gene Regulatory Networks; Hair; Humans; Male; Minoxidil; Reproduction; Risk Assessment; Risk Factors; Sex Factors; United States; United States Food and Drug Administration; Uterus | 2016 |
Interventions for Female Pattern Hair Loss.
Topics: Alopecia; Female; Finasteride; Hair; Humans; Minoxidil | 2017 |
Determination of illegal adulteration of dietary supplements with synthetic hair-growth compounds by UPLC and LC-Q-TOF/MS.
Topics: Chromatography, High Pressure Liquid; Dietary Supplements; Drug Contamination; Finasteride; Food Contamination; Hair; Minoxidil; Tandem Mass Spectrometry | 2018 |
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Drug Therapy, Combination; Dutasteride; Evidence-Based Medicine; Female; Finasteride; Hair; Humans; Low-Level Light Therapy; Male; Minoxidil; Outcome Assessment, Health Care; Platelet-Rich Plasma; Practice Guidelines as Topic; Vasodilator Agents | 2018 |
Development and validation of rapid and simultaneous method for determination of 12 hair-growth compounds in adulterated products by UHPLC-MS/MS.
Topics: Chromatography, High Pressure Liquid; Consumer Product Safety; Drug Contamination; Finasteride; Hair Preparations; Humans; Limit of Detection; Methyltestosterone; Minoxidil; Reproducibility of Results; Tandem Mass Spectrometry; Testosterone Propionate | 2018 |
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
Topics: Adenosine; Administration, Oral; Administration, Topical; Alopecia; Dutasteride; Female; Finasteride; Hair; Humans; Japan; Lasers, Semiconductor; Low-Level Light Therapy; Male; Minoxidil; Sex Factors; Treatment Outcome | 2018 |
Platelet rich plasma for the management of hair loss: Better alone or in combination?
Topics: Alopecia; Cell- and Tissue-Based Therapy; Combined Modality Therapy; Finasteride; Hair Follicle; Humans; Injections, Intradermal; Minoxidil; Platelet-Rich Plasma; Treatment Outcome | 2019 |
Controversies in the treatment of androgenetic alopecia: The history of finasteride.
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Administration, Topical; Alopecia; Finasteride; Hair; Humans; Male; Middle Aged; Minoxidil; Treatment Outcome; Vasodilator Agents | 2019 |
Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia.
Topics: Administration, Oral; Administration, Topical; Alopecia; Combined Modality Therapy; Finasteride; Humans; Male; Mesotherapy; Middle Aged; Minoxidil; Treatment Outcome | 2020 |
Reply to: "Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation".
Topics: Alopecia; Documentation; Finasteride; Humans; Male; Minoxidil | 2020 |
Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation.
Topics: Alopecia; Documentation; Finasteride; Humans; Male; Minoxidil | 2020 |
Evaluation of the effect of autologous platelet-rich plasma on androgenic alopecia.
Topics: Adolescent; Adult; Alopecia; Finasteride; Hair; Humans; Minoxidil; Platelet-Rich Plasma; Treatment Outcome; Young Adult | 2020 |
Development, validation, and application of an RP-HPLC method for concurrent quantification of Minoxidil and Finasteride in a topical solution for hair regrowth.
Topics: Chromatography, High Pressure Liquid; Finasteride; Indicators and Reagents; Lipids; Minoxidil | 2021 |
Development and Qualification of a Physiologically Based Pharmacokinetic Model of Finasteride and Minoxidil Following Scalp Application.
Topics: Finasteride; Minoxidil; Models, Biological; Scalp | 2021 |
"Comparison of QR 678
Topics: Alopecia; Combined Modality Therapy; Finasteride; Hair; Humans; Male; Minoxidil | 2021 |
Frontal edema due to mesotherapy for androgenetic alopecia: A case series.
Topics: Alopecia; Edema; Female; Finasteride; Humans; Male; Mesotherapy; Minoxidil; Retrospective Studies; Treatment Outcome | 2022 |
Before-after study with 24-hour ambulatory blood pressure monitoring after the first dose of 5 mg oral minoxidil.
Topics: Administration, Topical; Alopecia; Blood Pressure Monitoring, Ambulatory; Controlled Before-After Studies; Finasteride; Humans; Minoxidil; Treatment Outcome | 2022 |
What's New in Therapy for Male Androgenetic Alopecia?
Topics: Alopecia; Dutasteride; Finasteride; Humans; Male; Minoxidil; Retrospective Studies; Treatment Outcome | 2023 |
Digital health platforms expand access and improve care for male androgenetic alopecia.
Topics: Alopecia; Finasteride; Hair; Humans; Male; Minoxidil; Treatment Outcome | 2023 |
Evaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic Alopecia.
Topics: Alopecia; Female; Finasteride; Humans; Lasers, Solid-State; Male; Minoxidil; Platelet-Rich Plasma; Treatment Outcome | 2022 |
Real-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia.
Topics: Alopecia; Drug Administration Schedule; Female; Finasteride; Humans; Male; Minoxidil; Treatment Outcome | 2023 |
Investigation of oral finasteride enhanced occipital hair diameter index in different types of male androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Finasteride; Hair; Humans; Male; Minoxidil | 2023 |
Inverse androgenic alopecia.
Topics: Alopecia; Androgen Antagonists; Finasteride; Humans; Male; Minoxidil; Treatment Outcome | 2023 |